JP Morgan reduced its holdings in Guangzhou Baiyunshan Pharmaceutical Holdings (00874) by approximately 117,500 shares at a price of around HK$18.96 per share.
On November 4th, Citi reduced its holdings of Baiyunshan (00874) by 117,475 shares, with a price of 18.9589 Hong Kong dollars per share, totaling approximately 2.2272 million Hong Kong dollars.
According to the latest data from the Hong Kong Stock Exchange, on November 4th, JP Morgan reduced its holdings of Guangzhou Baiyunshan Pharmaceutical Holdings (00874) by 117,475 shares, at a price of HK$18.9589 per share, with a total amount of approximately HK$2.2272 million. After the reduction, the latest number of shares held is approximately 17.5819 million shares, with a new holding percentage of 7.99%.
Related Articles
IDREAMSKY (01119) granted 10,948,500 stock options.
KN Hospital(02120) spent about 944,100 Hong Kong dollars to repurchase 82,100 shares on November 7th.
WEIYE HOLDINGS (01570) recommends changing the auditor.
IDREAMSKY (01119) granted 10,948,500 stock options.
KN Hospital(02120) spent about 944,100 Hong Kong dollars to repurchase 82,100 shares on November 7th.
WEIYE HOLDINGS (01570) recommends changing the auditor.
RECOMMEND
Short Positions on Xiaomi (01810.HK) Surge 53% in a Week as Memory Price Spike Weighs on Sentiment
07/11/2025
Privatization Wave in Hong Kong Stocks: Exiting Liquidity Traps to Enable Strategic Transformation
07/11/2025
Over 30 Foreign Firms Attend Roundtable as Ministry of Commerce Signals Multiple Policy Shifts
07/11/2025
